Personalized vaccine shows promise in ovarian cancer trial
NCT ID NCT03839524
First seen Nov 15, 2025 · Last updated May 22, 2026 · Updated 25 times
Summary
This early-stage trial tested a new personalized immunotherapy called TG4050 in 64 women with advanced ovarian, fallopian tube, or peritoneal cancer. All participants had completed standard chemotherapy and were in complete remission. The main goal was to check the treatment's safety and tolerability, while also looking at signs of immune response and tumor control. The study did not aim to cure the disease, but to explore a new way to help control it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Pitié-Salpêtrière
Paris, 75013, France
-
IUCT Toulouse
Toulouse, 31100, France
-
Institut Curie
Paris, 75005, France
-
Mayo Clinic Jacksonville
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Phoenix
Phoenix, Arizona, 85259, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.